XOLYXIB 100 MG TABLETAS RECUBIERTAS 파나마 - 영어 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

xolyxib 100 mg tabletas recubiertas

laboratorio franco colombiano lafrancol, s.a.s. - bosutinib (monohidrato) - bosutinib (monohidrato)....100 mg

Volopem 500 MG/1 TAB 요르단 - 영어 - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

volopem 500 mg/1 tab

شركة أدوية الحكمة - hikma pharmaceuticals - bosutinib (as bosutinib monohydrate) 500 mg/1 tab - 500 mg/1 tab

Volopem 100 MG/1 TAB 요르단 - 영어 - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

volopem 100 mg/1 tab

شركة أدوية الحكمة - hikma pharmaceuticals - bosutinib (as bosutinib monohydrate) 100 mg/1 tab - 100 mg/1 tab

Bosulif tablets 100mg (ボシュリフ錠100mg) 일본 - 영어 - すりの適正使用協議会 RAD-AR Council, Japan

bosulif tablets 100mg (ボシュリフ錠100mg)

pfizer pharmaceuticals inc. - bosutinib hydrate - yellow tablet, major axis: approx. 10.6 mm, minor axis: approx. 5.5 mm, thickness: approx. 3.1 mm

Itrazole 뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

itrazole

viatris limited - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis

Sporanox 뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sporanox

janssen-cilag (new zealand) ltd - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: erythrosine gelatin   hypromellose indigo carmine macrogol 20000 sugar spheres titanium dioxide - sporanox capsules are indicated for the following conditions: - treatment of vulvovaginal candidiasis. - treatment of pityriasis versicolor. - treatment of dermatomycosis – including highly keratinised regions as in plantar tinea pedis and palmer tinea manus. - treatment of fungal keratitis. - treatment of oral candidiasis. - treatment of onychomycosis caused by dermatophytes and/or yeasts. - systemic mycoses, only in the following fungal infections: o treatment of systemic aspergillosis and candidiasis, o treatment of histoplasmosis, o histoplasmosis, maintenance therapy only in aids patients. o treatment of sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous), o treatment of paracoccidioidomycosis, o treatment of chromomycosis, o treatment of blastomycosis.